Patent · US Expired

Method for making a monoclonal antibody, monoclonal antibodies to .alpha. P D

US5468468A · kind A · utility

18Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 1993
Grant dateNov 21, 1995
Priority date
Expiry dateJun 25, 2013

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Potent neutralizing monoclonal antibodies to the human .alpha. PDGF receptor (.alpha. PDGFR) and fragments thereof are described. These monoclonal antibodies specifically bind to an epitope on .alpha. PDGFR, inhibits PDGF binding with PDGF, antagonizes PDGF, and does not bind .beta. PDGFR receptor. A hybridoma cell line producing such a monoclonal antibody, methods of in vivo imaging of a pathological conditions and methods of inhibiting the growth of a neoplasia expressing .alpha. PDGFR, which use these monoclonal antibodies are also described. In vitro assays for detecting the presence of .alpha. PDGFR and for evaluating the binding affinity of a test compound are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.